These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 1299465

  • 1. Quality of life consequences of chemotherapy-induced emesis.
    Lindley CM, Hirsch JD, O'Neill CV, Transau MC, Gilbert CS, Osterhaus JT.
    Qual Life Res; 1992 Oct; 1(5):331-40. PubMed ID: 1299465
    [Abstract] [Full Text] [Related]

  • 2. Assessing the impact of chemotherapy-induced nausea and vomiting on patients' daily lives: a modified version of the Functional Living Index-Emesis (FLIE) with 5-day recall.
    Martin AR, Pearson JD, Cai B, Elmer M, Horgan K, Lindley C.
    Support Care Cancer; 2003 Aug; 11(8):522-7. PubMed ID: 12827483
    [Abstract] [Full Text] [Related]

  • 3. Impact of chemotherapy-associated nausea and vomiting on patients' functional status and on costs: survey of five Canadian centres.
    O'Brien BJ, Rusthoven J, Rocchi A, Latreille J, Fine S, Vandenberg T, Laberge F.
    CMAJ; 1993 Aug 01; 149(3):296-302. PubMed ID: 8339175
    [Abstract] [Full Text] [Related]

  • 4. Impact of adherence to antiemetic guidelines on the incidence of chemotherapy-induced nausea and vomiting and quality of life.
    Abunahlah N, Sancar M, Dane F, Özyavuz MK.
    Int J Clin Pharm; 2016 Dec 01; 38(6):1464-1476. PubMed ID: 27796777
    [Abstract] [Full Text] [Related]

  • 5. Measuring the maintenance of daily life activities using the functional living index-emesis (FLIE) in patients receiving moderately emetogenic chemotherapy.
    Decker GM, DeMeyer ES, Kisko DL.
    J Support Oncol; 2006 Jan 01; 4(1):35-41, 52. PubMed ID: 16444851
    [Abstract] [Full Text] [Related]

  • 6. Assessing the impact of chemotherapy-induced nausea and vomiting on patients' quality of life: An Arabic version of the Functional Living Index-Emesis.
    Alhammad AM, Alkhudair N, Alzaidi R, Almosabhi LS, Aljawadi MH.
    J Oncol Pharm Pract; 2022 Apr 01; 28(3):535-541. PubMed ID: 33645326
    [Abstract] [Full Text] [Related]

  • 7. The impact of chemotherapy-induced nausea and vomiting on health-related quality of life.
    Ballatori E, Roila F, Ruggeri B, Betti M, Sarti S, Soru G, Cruciani G, Di Maio M, Andrea B, Deuson RR.
    Support Care Cancer; 2007 Feb 01; 15(2):179-85. PubMed ID: 16941136
    [Abstract] [Full Text] [Related]

  • 8. Delayed nausea and vomiting continue to reduce patients' quality of life after highly and moderately emetogenic chemotherapy despite antiemetic treatment.
    Bloechl-Daum B, Deuson RR, Mavros P, Hansen M, Herrstedt J.
    J Clin Oncol; 2006 Sep 20; 24(27):4472-8. PubMed ID: 16983116
    [Abstract] [Full Text] [Related]

  • 9. Impact on daily functioning and indirect/direct costs associated with chemotherapy-induced nausea and vomiting (CINV) in a U.S. population.
    Haiderali A, Menditto L, Good M, Teitelbaum A, Wegner J.
    Support Care Cancer; 2011 Jun 20; 19(6):843-51. PubMed ID: 20532923
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of the 3-day recall period for the Functional Life Index-Emesis (FLIE).
    Wan BA, Drost L, Ganesh V, Zhang L, Yee C, Tsao M, Barnes E, Pasetka M, DeAngelis C, Chow E.
    Ann Palliat Med; 2018 Oct 20; 7(4):393-403. PubMed ID: 30180722
    [Abstract] [Full Text] [Related]

  • 11. Impact of radiation-induced nausea and vomiting on quality of life.
    Yee C, Drost L, Zhang L, Wan BA, Ganesh V, Tsao M, Barnes E, Pasetka M, DeAngelis C, Chow E.
    Support Care Cancer; 2018 Nov 20; 26(11):3959-3966. PubMed ID: 29808378
    [Abstract] [Full Text] [Related]

  • 12. A randomized study of aprepitant, ondansetron and dexamethasone for chemotherapy-induced nausea and vomiting in Chinese breast cancer patients receiving moderately emetogenic chemotherapy.
    Yeo W, Mo FK, Suen JJ, Ho WM, Chan SL, Lau W, Koh J, Yeung WK, Kwan WH, Lee KK, Mok TS, Poon AN, Lam KC, Hui EK, Zee B.
    Breast Cancer Res Treat; 2009 Feb 20; 113(3):529-35. PubMed ID: 18327706
    [Abstract] [Full Text] [Related]

  • 13. Symptom clusters of gastrointestinal cancer patients undergoing radiotherapy using the Functional Living Index-Emesis (FLIE) quality-of-life tool.
    Poon M, Dennis K, DeAngelis C, Chung H, Stinson J, Zhang L, Bedard G, Wong E, Popovic M, Lao N, Pulenzas N, Wong S, Cheon P, Chow E.
    Support Care Cancer; 2015 Sep 20; 23(9):2589-98. PubMed ID: 25620759
    [Abstract] [Full Text] [Related]

  • 14. Rolapitant improves quality of life of patients receiving highly or moderately emetogenic chemotherapy.
    Chasen M, Urban L, Schnadig I, Rapoport B, Powers D, Arora S, Navari R, Schwartzberg L, Gridelli C.
    Support Care Cancer; 2017 Jan 20; 25(1):85-92. PubMed ID: 27557833
    [Abstract] [Full Text] [Related]

  • 15. Randomized double-blind study of the Reliefband as an adjunct to standard antiemetics in patients receiving moderately-high to highly emetogenic chemotherapy.
    Treish I, Shord S, Valgus J, Harvey D, Nagy J, Stegal J, Lindley C.
    Support Care Cancer; 2003 Aug 20; 11(8):516-21. PubMed ID: 12836088
    [Abstract] [Full Text] [Related]

  • 16. [Development of a Japanese version of the FLIE].
    Satou A, Yamazaki T, Nukariya N, Nakamachi M, Shimada K, Matsukawa M, Kurihara M.
    Gan To Kagaku Ryoho; 2002 Feb 20; 29(2):281-91. PubMed ID: 11865635
    [Abstract] [Full Text] [Related]

  • 17. A retrospective review of antiemetic use for chemotherapy-induced nausea and vomiting in pediatric oncology patients at a tertiary care center.
    Aseeri M, Mukhtar A, Al Khansa S, Elimam N, Jastaniah W.
    J Oncol Pharm Pract; 2013 Jun 20; 19(2):138-44. PubMed ID: 23034405
    [Abstract] [Full Text] [Related]

  • 18. [The development of a new QOL Questionnaire on chemotherapy - induced emesis and vomiting--investigation of reliability and validity. Group for Investigation of QOL Questionnaire for Anti-Emetics Used in Cancer Chemotherapy. Joint Research Group for Tropisetron Double-Blind Comparative study].
    Ishihara Y, Nukariya N, Kobayashi K, Yoneda S, Matsuda T, Yakushiji M, Yamakido M, Fukuoka M, Niitani H, Furue H.
    Gan To Kagaku Ryoho; 1996 May 20; 23(6):745-55. PubMed ID: 8645026
    [Abstract] [Full Text] [Related]

  • 19. Can treatment with Cocculine improve the control of chemotherapy-induced emesis in early breast cancer patients? A randomized, multi-centered, double-blind, placebo-controlled Phase III trial.
    Pérol D, Provençal J, Hardy-Bessard AC, Coeffic D, Jacquin JP, Agostini C, Bachelot T, Guastalla JP, Pivot X, Martin JP, Bajard A, Ray-Coquard I.
    BMC Cancer; 2012 Dec 17; 12():603. PubMed ID: 23244208
    [Abstract] [Full Text] [Related]

  • 20. Impact of chemotherapy-induced nausea and vomiting on quality of life in indonesian patients with gynecologic cancer.
    Perwitasari DA, Atthobari J, Mustofa M, Dwiprahasto I, Hakimi M, Gelderblom H, Putter H, Nortier JW, Guchelaar HJ, Kaptein AA.
    Int J Gynecol Cancer; 2012 Jan 17; 22(1):139-45. PubMed ID: 22080888
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.